Pharma channel feed

Keytru­da adds new FDA ap­proval for a rare form of mesothe­lioma

7 months ago
R&D

Sen­a­tors tell FDA that ‘greater ac­tion is need­ed’ to use man­u­fac­tur­ing tech in US sup­ply chains

7 months ago
FDA+
Manufacturing

Ther­at­e­ch­nolo­gies' HIV drug to face sup­ply is­sues in 2025 over third-par­ty fa­cil­i­ty shut­down 

7 months ago
FDA+
Manufacturing

No­var­tis’ Kisqali snags FDA ap­proval to re­duce re­cur­rence in pa­tients with ear­ly forms of breast can­cer

7 months ago
FDA+

CD­MO Serán sets out to build first com­mer­cial fa­cil­i­ty, with a $200M in­vest­ment led by Bain Cap­i­tal

7 months ago
Manufacturing

Co­herus warns of lim­it­ed can­cer drug sup­ply due to third-par­ty ‘ca­pac­i­ty con­straints’

7 months ago
Manufacturing

Cigna sues FTC, call­ing for with­draw­al of 'bi­ased, er­ro­neous' PBM re­port

7 months ago
Law
Health Tech

Sun, sur­pris­es and new sum­mits at Eu­rope’s biggest can­cer con­fer­ence

8 months ago
R&D

Af­ter land­ing a key win in a com­mon can­cer con­di­tion, Pfiz­er faces a big test in Phase 3

8 months ago
R&D

FDA ap­proves Lil­ly's eczema drug Ebglyss for mod­er­ate-to-se­vere dis­ease

8 months ago
FDA+

Roche out­lines com­mer­cial man­u­fac­tur­ing strat­e­gy for GLP-1/GIP as­sets 

8 months ago
Manufacturing

In sur­prise, study sug­gests Covid mR­NA vac­cines may boost can­cer im­munother­a­py ef­fi­ca­cy

8 months ago
R&D
Coronavirus

Keytru­da and Lenvi­ma still have an­oth­er hill to climb fol­low­ing lat­est da­ta drop

8 months ago
R&D

As­traZeneca un­veils what it calls ‘prac­tice-chang­ing’ Imfinzi da­ta in blad­der can­cer

8 months ago
R&D

In­cyte gears up to face FDA once again with more Zynyz da­ta in rare anal can­cer

8 months ago
R&D

Up­dat­ed: GSK, iTeos re­ju­ve­nate strug­gling TIG­IT space with pos­i­tive Phase 2 Jem­per­li com­bo da­ta in lung can­cer

8 months ago
R&D

Ad­comm says In­ter­cep­t's rare liv­er dis­ease drug should not get full ap­proval

8 months ago
FDA+

FDA ap­proves sub­cu­ta­neous Ocre­vus, broad­en­ing ac­cess to Roche and Genen­tech block­buster

8 months ago
FDA+

WHO pre-qual­i­fies Bavar­i­an Nordic’s vac­cine as first mpox shot

8 months ago
Manufacturing

On­line stim­u­lant pre­scrip­tions soared dur­ing Covid pan­dem­ic, study finds

8 months ago
Health Tech

Cor­rect­ed: Roche’s Tecen­triq scores first US ap­proval for sub­cu­ta­neous PD-L1

8 months ago
FDA+

Avadel's nar­colep­sy drug Lum­ryz miss­es PDU­FA date, still un­der re­view at FDA

8 months ago
FDA+

FDA should em­brace new ways of eval­u­at­ing rare dis­ease drugs, re­port ar­gues

8 months ago
FDA+

Gilead says twice-year­ly HIV pre­ven­tion shot suc­ceeds in sec­ond piv­otal tri­al

8 months ago
R&D
First page Previous page 33343536373839 Next page Last page
A service from the Financial Times